i3L Power Talk with Merck : The Latest Update on Vaccine Development

Around the globe, more than 135 potential vaccines developed by research institutes and pharmaceutical companies have joined the race to find a cure for COVID-19. To date, however, it is difficult to ascertain as to when the vaccine will be available. In this Power Talk Edition, Asanga Halangoda , Head of Research Business, Ilma Robert Equilibrina, Segment Manager and Sri Hayuni , Research Specialist at Merck Life Sciences, will give the latest update on the global collaborations to develop COVID-19 vaccines, including the efforts to develop vaccines in Indonesia, identify key challenges, and provide recommendations on how we can collectively speed up the development of an effective vaccine.